Answer:
The beta of stock T is 1.82
Explanation:
The portfolio beta is made up of the weighted average of the individual stock betas in the portfolio.
The formula for portfolio beta is,
Portfolio beta = wA * beta of A + wB * beta of B + ... + wX * beta of X
The weight of stock T in the portfolio is = 1 - (0.11 + 0.56) = 0.33 or 33%
Let beta of Stock T be x. The beta of Stock T is:
1.47 = 0.11 * 0.84 + 0.56 * 1.39 + 0.33 * x
1.47 = 0.0924 + 0.7784 + 0.33x
1.47 - 0.0924 - 0.7784 = 0.33x
0.5992 / 0.33 = x
x = 1.815 rounded off to 1.82
Answer:
$62,100
Explanation:
Given that,
Sales price per unit = $ 40
Variable costs per unit:
Manufacturing = $ 23
Marketing and administrative = $ 8
Total fixed costs:
Manufacturing = $ 76,000
Marketing and administrative = $24,000
Total incremental costs:
= Variable manufacturing + Variable marketing and administrative
= (6,900 × $23) + (6,900 × $8)
= $158,700 + $55,200
= $213,900
Incremental income:
= Incremental revenue - Total incremental costs
= (6,900 × $40) - $213,900
= $276,000 - $213,900
= $62,100
Therefore, the operating income increases by $62,100.
Answer:
$12 and $180
Explanation:
The computation of the predetermined overhead rate is shown below:
As we know that
The predetermined overhead rate is
= Estimated total indirect cost ÷ expected direct labor hours
= $96,000 ÷ 8,000
= $12
And, the indirect cost is
= Predetermined overhead rate × number of hours
= $12 × 15
= $180
We simply applied the above formula
Answer:
SWOT ANALYSIS
Explanation:
A SWOT analysis looks at internal and external factors that can affect a business.
In SWOT analysis Internal factors are strengths and weaknesses. External factors are the threats and opportunities. An example of an external factor is changes in technology or a new government policy.
The Strategic planning process implored by Raney Pharmaceuticals Corp should help them:
1. respond to new trends
Since more people are becoming interested in natural alternatives to traditional chemical pharmaceuticals and the trend is expected to continue over the next decade Raney Pharmaceuticals Corp could take advantage of this opportunity by diversifying to produce natural alternative medication.
2. Discover threats (external factor)
Since New regulations have been passed limiting their ability to sell certain formulations over the counter, it would likely reduce their sales.
3. Overcome Weakness
The company has inadequate financial resources to invest in their operations and thus would need to get new investors.
Also, since they have fallen behind in research and development in the last few years adequate measures should be taken to improve their research and development.
